v3.25.1
Stock Based Compensation (FY) (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Summary of Recognized Stock Based Compensation

For the three months ended March 31, 2025 and 2024, the Company recognized stock-based compensation expense as follows:

 
Three Months Ended March 31,
(Amounts in 000’s)
2025
2024
Employee compensation:
 
 
Stock compensation expense
$22
$43
Total employee stock-based compensation expense
$22
$43

The following table summarizes employee stock-based compensation for the years ended December 31, 2024 and 2023:

 
Year Ending December 31,
Amounts in (000's)
2024
2023
Employee compensation:
 
 
Stock options
$42
$72
Restricted stock
72
285
Total employee stock-based compensation expense
$114
$357
Summary of Company's Stock Option Activity

The following summarizes the Company's employee stock option activity for the three months ended March 31, 2025:

 
Number of
Shares (000's)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value (000's)
Outstanding, December 31, 2024
48
$2.68
8.5
$
Granted
$
Outstanding, March 31, 2025
48
$2.68
8.3
$17.9
Outstanding and Vested, March 31, 2025
48
$2.68
8.3
$17.9

The following summarizes the Company’s employee and non-employee stock option activity for the years ended December 31, 2024 and 2023:

 
Number of
Options
(000's)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contract Life
(in years)
Aggregate
Intrinsic
Value (000's)
Outstanding at December 31, 2022
13
$47.53
1.6
$—
Granted
24
$3.32
 
 
Expired
(4)
$48.96
 
 
Outstanding at December 31, 2023
33
$14.84
6.9
$
Granted
24
$2.03
 
 
Expired
(9)
$46.80
 
 
Outstanding at December 31, 2024
48
$2.68
8.5
$—
Schedule of Exercise Price Range

The following summary information reflects stock options outstanding, vested, and related details as of March 31, 2025:

 
Stock Options Outstanding
Stock Options Exercisable
Exercise Price
Number of
Shares (000's)
Weighted
Average
Remaining
Contractual
Term
(in years)
Weighted
Average
Exercise
Price
Number of
Shares (000's)
Weighted
Average
Exercise
Price
$2.03-$3.32
48
8.3
$2.68
48
$2.68

The following summary information reflects stock options outstanding, vested, and related details as of December 31, 2024:

 
Stock Options Outstanding
Stock Option Exercisable
Exercise Price
Number
Outstanding
(000's)
Weighted
Average
Remaining
Contractual
Term
(in years)
Weighted
Average
Exercise
Price
Vested and
Exercisable
(000's)
Weighted
Average
Exercise
Price
$2.03
24
9.0
$2.03
11
$2.03
$3.32
24
8.0
$3.32
24
$3.32
Total
48
8.5
$2.68
35
$2.91
Summary of Company's Restricted Stock Activity

The following table summarizes the Company's restricted stock activity for the three months ended March 31, 2025:

 
Number of
Shares (000's)
Weighted Avg.
Grant Date
(per Share)
Fair Value
Unvested, December 31, 2024
86
$2.61
Vested
(13)
$3.61
Unvested, March 31, 2025
73
$2.43

The following summarizes the Company’s restricted stock activity for the years ended December 31, 2024 and 2023:

 
Number
of
Shares (000's)
Weighted
Average
Grant Date
Fair Value
Unvested at December 31, 2022
51
$8.99
Granted
99
$3.61
Vested
(26)
$9.06
Forfeited
(44)
$3.61
 
Number
of
Shares (000's)
Weighted
Average
Grant Date
Fair Value
Unvested at December 31, 2023
80
$5.27
Granted
65
$2.18
Vested
(43)
$6.67
Forfeited
(16)
$3.15
Unvested at December 31, 2024
86
$2.61
Warrants    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Schedule of Exercise Price Range  

The following summary information reflects warrants outstanding, vested, and related details as of December 31, 2024:

 
Warrants Outstanding
Warrants Exercisable
Exercise Price
Number
Outstanding
(000's)
Weighted
Average
Remaining
Contractual
Term
(in years)
Weighted
Average
Exercise
Price
Vested and
Exercisable
(000's)
Weighted
Average
Exercise
Price
$51.00
15
0.2
$51.00
15
$51.00
Total
15
0.2
$51.00
15
$51.00
Schedule of Common Stock Warrant Activity

The following summarizes the Company's warrant activity for the three months ended March 31, 2025:

 
Number of
Warrants (000's)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
(in 000's)
Outstanding and Vested, December 31, 2024
15
$51.00
0.2
$—
Granted
$
 
 
Outstanding and Vested, March 31, 2025
15
$51.00
$—

The following summarizes the Company’s employee and non-employee common stock warrant activity for the years ended December 31, 2024 and 2023:

 
Number of
Warrants
(000's)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contract Life
(in years)
Aggregate
Intrinsic
Value (000's)
Outstanding at December 31, 2022
35
$53.31
1.9
$—
Granted
$
 
 
Expired
(3)
$63.81
 
 
Outstanding at December 31, 2023
32
$52.50
1.0
$—
Granted
$
 
 
Expired
(17)
$53.88
 
 
Outstanding at December 31, 2024
15
$51.00
0.2
$—